Business Wire

THE-PENINSULA-HOTELS

9.2.2021 07:02:26 CET | Business Wire | Press release

Share
1954 Ferrari 750 Monza Wins the Peninsula Classics 2020 Best of the Best Award

The Peninsula Hotels, whose international hospitality brand has epitomised glamour and luxury for nearly a century, today announced the winner of its sixth annual classic car showcase, The Peninsula Classics 2020 Best of the Best Award. The winning car, the 1954 Ferrari 750 Monza, coachwork by Scaglietti , has achieved distinction both for its impressive racing history and its exacting restoration. It became eligible as a Best of the Best Award contender after winning Best of Show at the 2020 Palm Beach Cavallino Classic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005295/en/

The Best of the Best Award was co-founded in 2015 by The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited (owner and operator of The Peninsula Hotels), along with William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. The Award celebrates the fine engineering and design of classic cars built by internationally renowned manufacturers, selected from an exceptional short list of winners from the most exclusive concours. This year’s award has a contracted list of nominees due to cancellation or postponement of partner concours in 2020 as a result of the COVID-19.

The 1954 Ferrari 750 Monza was chosen from a selection of four nominees crafted by automakers from Italy, Germany, and the United States, including a 1969 Porsche 917 KH Coupé, coachwork by the Factory, 2020 Best of Show, Concours of Elegance Hampton Court Palace, 1931 Alfa Romeo 8C 2300 Monza Spider, coachwork by Zagato, 2020 Best of Show, Salon Privé and a 1929 Duesenberg Model J Town Limousine, coachwork by Murphy, 2020 Best of Show, Amelia Island Concours d’Elegance.

The winner was selected by The Best of the Best Award’s esteemed panel of judges, including, amongst others, designers Gordon Murray (former Formula 1 designer for Brabham and McLaren) and Anne Asensio (Vice President of Design Experience at Dassault Systèmes), and prominent classic car collectors Laurence Graff and Jay Leno.

“It was a difficult task for our judges to select a winner this year. Our judging procedures had to be carried out remotely and unfortunately the main awards event had to be cancelled, with social distancing measures and safety our top priority,” said The Hon. Sir Michael Kadoorie. “With such a prestigious collection of nominees, choosing one winner was especially challenging. However, it is always a great pleasure to spotlight the remarkable achievements of the automotive industry, and to create a small spark of joy in the current challenging times. These classic vehicles are an enduring testament to human artistry and ingenuity.”

The winning 750 Monza made its original debut with a 2-litre motor at the Inaugural Grand Prix of the Imola Autodrome in June of 1954. After driver Umberto Maglioli secured first place for Scuderia Ferrari with the car, it was subsequently fitted with a 3-litre engine and went on to compete in several other major races that year, including the Monsanto Grand Prix (where it won), and Nassau Race Week – where it was driven by its original owner, Alfonso de Portago, and secured a 1st and two 2nd places.

The car’s next owner, Sterling Edwards, raced the 750 Monza over the next two years mainly in California, including the Pebble Beach Road Races (an event he founded) in 1955 and 1956 – garnering four 1st-place and two first-in-class wins in the car. After the tragic death of his friend Ernie McAfee prompted Edwards to stop racing altogether, he sold the car to his engineer Bob Whitmer, who replaced its engine with a Chevy V8 and continued to successfully race it through the early 1960s.

The car spent most of the ensuing 50 years disassembled, though its chassis, body, engine, and gearbox were all carefully preserved in a small San Francisco-area warehouse. In 2016, a complete restoration of the car was initiated under the direction of Bob Smith Coachworks, located in Gainesville, Texas, a process that took new owners Tom and Jill Peck of southern California over two years to complete.

The refurbishment was guided by several noted Ferrari historians: Marcel Massini of Switzerland, Alan Boe of Braselton, Georgia, David Seielstad of Hawaii, as well as past owners Sterling Edwards’ son Hammond and Bob Whitmer, both from northern California. The vintage certification team at Ferrari Classiche in Maranello, Italy, was also helpful in piecing together the early racing career of the car while campaigned by Ferrari. Bringing their combined wealth of knowledge to the project, these experts employed many of the vehicle’s preserved original documents and instruments, including the original owners’ manual, toolboxes, build sheets, and a treasure trove of original photographs of the car. Computer modelling of these photos was employed to repair flaws in the body from the car’s racing days, and 3-D printing technology was utilised to duplicate some parts that were irreparable. The vehicle’s livery was restored to that which it sported in its first Carrera Panamericana race in 1954.

Once fully restored, the 1954 Ferrari 750 Monza won the Enzo Ferrari Award at the 2019 Pebble Beach Concours d’Elegance and 2020 Best of Show at the Cavallino Classic, before being named winner of The Peninsula Classics 2020 Best of the Best Award.

“It is a true honour to be recognised by the venerable judges of The Peninsula Classics,” said Mr. Peck of his car’s latest success. “Like so many classic cars, this one has been both a labour of love and the product of dedicated teamwork. The Best of the Best Award is a crowning achievement for everyone involved.”

About The Peninsula Classics Best of the Best Award

Through a shared desire to celebrate the best of what defines the automotive world, The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited, launched The Peninsula Classics Best of the Best Award in 2015 with co-founders William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. Each founder shares a common passion and appreciation of fine motor cars, the preservation of their heritage and immaculate restoration projects. The award, sponsored by The Peninsula Hotels , brings together elite ‘Best of Show’ winners from nine of the renown concours circuits around the globe: Amelia Island Concours d’Elegance, Cavallino Classic, Chantilly Arts & Elegance Richard Mille, Concorso d’Eleganza Villa d’Este, Concours of Elegance Hampton Court Palace, Goodwood Cartier Style et Luxe Concours d’Elegance, Pebble Beach Concours d’Elegance, Salon Privé, and The Quail, A Motorsports Gathering.

Link:

ClickThru

Social Media:

https://www.facebook.com/ThePeninsulaHotels

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 07:00:00 CEST | Press release

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the

Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 04:00:00 CEST | Press release

Milestone-based government program supports multiple fusion approaches toward power demonstration and commercialization Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated ove

Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]31.8.2026 23:35:00 CEST | Press release

ITC Infotech Board approves proposed acquisition of 22.1% promoter stake and a Scheme of Amalgamation of the two companies ITC Infotech (ITCI), a wholly owned subsidiary of ITC Limited and a leading global technology services player, today announced the proposed strategic combination with Happiest Minds Technologies Limited (Happiest Minds) to create a scaled, future-ready, AI-first global technology services enterprise. The ITCI Board approved a proposal to acquire 22.1% equity stake from the promoter of Happiest Minds in two tranches under a Share Purchase Agreement. The transaction would be funded through a Rights Issue by ITC Infotech. ITCI Board has also approved a proposed Scheme of Amalgamation of Happiest Minds with ITCI which will be effected after the share acquisition. Pursuant to the scheme, the shares of ITCI will be listed on the stock exchanges. The proposed transaction has also been endorsed by the Board of Directors of ITC Limited. This strategic combination will syner

Angel’s Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule31.8.2026 21:07:00 CEST | Press release

Angelalign Technology Inc. (“Angel” or the “Company”) (6699.HK) (angelaligner.com), the second largest clear aligner supplier by revenue, announced today that its revenue grew 42.9% to US$230.7 million and net profit grew 79.6% to $25.5 million for the six months ending June 30, 2026. Angel’s business in Europe and North America crossed into profitability ahead of plan while the business in Chinese mainland delivered market share gains well above expectations. Doctors and staff in every region report that they are increasingly selecting Angel’s solutions after experiencing more predictable outcomes, especially on complex cases, and embracing the positive culture of the company. Dr. Mark Holt D.D.S., M.S. of Holt Orthodontics in Northern California, states: “We treat over half of our patients with clear aligners and our experience with Angel’s treatment plans and clear aligners has been tremendous.” “Our main focus is to provide great service to and being a rock-solid partner for our cu

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines31.8.2026 21:00:00 CEST | Press release

Agreement advances patient access and strengthens BeOne's long-term commitment to U.S. innovation and manufacturing BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as we expand our U.S. investment in additional res

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye